Promega corporation:1107424 - hdac-GLO(TM) I/II assay, 100ML for menghang XIA
Ended Awarded
- Contract number
- HHSN31900001
- Awardee
-
Promega Corporation UEI MWM4N9L4S5X4
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $24,966
Award facts
- Contract value 50% obligated
-
- $24,966.20 Current, with exercised options
- $49,932.40 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53711, USA
Award details come from SAM.gov/FPDS.
About this award
Promega Corporation received a Firm Fixed Price Blanket Purchase Agreement (BPA) call valued at $49,932.40 from the National Center for Advancing Translational Sciences (NCATS) for HDAC-GLO I/II Assay products in a 100 mL quantity designated for researcher Menghang Xia. The contract was awarded on March 6, 2015, with an ultimate completion date of February 29, 2016, and does not utilize a small business set-aside designation. The work is to be performed at Promega's facility in Madison, Wisconsin.
This procurement falls under Promega's existing $10 million BPA with the National Institutes of Health's Office of Logistics and Acquisition Operations, which covers biological materials, chemicals, medical and scientific equipment, and associated services. NCATS, a component of NIH focused on translational science to accelerate the development of diagnostics and therapeutics, regularly issues task orders under this vehicle for specialized assay products and laboratory reagents to support its research initiatives. The HDAC-GLO assay represents a specialized luminescent detection reagent commonly used in epigenetic and drug screening research applications.
Quick answers
Who was awarded contract HHSN31900001?
HHSN31900001 was awarded to Promega Corporation by National Center for Advancing Translational Sciences (National Institutes of Health) on March 6, 2015.
How much is contract HHSN31900001 worth?
The government has obligated $24,966 on HHSN31900001. Its potential value, with all options, is $49,932.
Is contract HHSN31900001 an order under another contract?
Yes. HHSN31900001 is a BPA call under HHSN263201500038B, a blanket purchase agreement.
Was contract HHSN31900001 competed?
The extent of competition for HHSN31900001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award